BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27153315)

  • 1. IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195.
    Ye S; Song W; Xu X; Zhao X; Yang L
    FEBS Lett; 2016 Jun; 590(11):1641-50. PubMed ID: 27153315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
    Wang Y; Lu JH; Wu QN; Jin Y; Wang DS; Chen YX; Liu J; Luo XJ; Meng Q; Pu HY; Wang YN; Hu PS; Liu ZX; Zeng ZL; Zhao Q; Deng R; Zhu XF; Ju HQ; Xu RH
    Mol Cancer; 2019 Dec; 18(1):174. PubMed ID: 31791342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
    Xu X; Yu Y; Zong K; Lv P; Gu Y
    J Exp Clin Cancer Res; 2019 Dec; 38(1):497. PubMed ID: 31852504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.
    Chai J; Wang S; Han D; Dong W; Xie C; Guo H
    Tumour Biol; 2015 Feb; 36(2):1313-21. PubMed ID: 25355599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
    Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
    RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Knockdown of IGF2BP2 inhibits colorectal cancer cell proliferation, migration and promotes tumor immunity by down-regulating MYC expression].
    Liu T; Han C; Hu C; Mao S; Sun Y; Yang S; Yang K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):303-310. PubMed ID: 37087547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.
    Suto T; Yokobori T; Yajima R; Morita H; Fujii T; Yamaguchi S; Altan B; Tsutsumi S; Asao T; Kuwano H
    Carcinogenesis; 2015 Mar; 36(3):338-45. PubMed ID: 25503932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m
    Yao B; Zhang Q; Yang Z; An F; Nie H; Wang H; Yang C; Sun J; Chen K; Zhou J; Bai B; Gu S; Zhao W; Zhan Q
    Mol Cancer; 2022 Jun; 21(1):140. PubMed ID: 35773744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer.
    Cui H; Liu Y; Jiang J; Liu Y; Yang Z; Wu S; Cao W; Cui IH; Yu C
    Oncotarget; 2016 Jul; 7(30):48456-48466. PubMed ID: 27366946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism.
    Liu TY; Hu CC; Han CY; Mao SY; Zhang WX; Xu YM; Sun YJ; Jiang DB; Zhang XY; Zhang JX; Wang J; Qiao XP; Pan JY; Yang SY; Yang K
    Biol Direct; 2023 Apr; 18(1):19. PubMed ID: 37088822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.
    Wu F; Zhou J
    BMC Cancer; 2019 Nov; 19(1):1067. PubMed ID: 31703640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA 91H regulates IGF2 expression by interacting with IGF2BP2 and promotes tumorigenesis in colorectal cancer.
    Gao T; Liu X; He B; Pan Y; Wang S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):664-671. PubMed ID: 32070145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing
    Yang W; Ning N; Jin X
    Biomed Res Int; 2017; 2017():2767484. PubMed ID: 28164117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.
    Weng W; Wei Q; Toden S; Yoshida K; Nagasaka T; Fujiwara T; Cai S; Qin H; Ma Y; Goel A
    Clin Cancer Res; 2017 Jul; 23(14):3918-3928. PubMed ID: 28174233
    [No Abstract]   [Full Text] [Related]  

  • 17. A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
    Kendzia S; Franke S; Kröhler T; Golob-Schwarzl N; Schweiger C; Toeglhofer AM; Skofler C; Uranitsch S; El-Heliebi A; Fuchs J; Punschart A; Stiegler P; Keil M; Hoffmann J; Henderson D; Lehrach H; Yaspo ML; Reinhard C; Schäfer R; Keilholz U; Regenbrecht C; Schicho R; Fickert P; Lax SF; Erdmann F; Schulz MH; Kiemer AK; Haybaeck J; Kessler SM
    Mol Cancer; 2023 May; 22(1):89. PubMed ID: 37248468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor functions of miR-133a in colorectal cancer.
    Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
    Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
    Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
    Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Zhao D; Sui Y; Zheng X
    Oncol Rep; 2016 Feb; 35(2):1075-82. PubMed ID: 26718987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.